Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1

NCT03560323 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure
Type 2 Diabetes Mellitus

Interventions

DRUG: Beta-hydroxy-butyrate

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]